218 related articles for article (PubMed ID: 4628703)
1. Studies on the properdin system: isolation of a heat-labile factor from guinea pig serum related to a human glycine rich beta-glycoprotein (GBG or factor B).
Brade V; Cook CT; Shin HS; Mayer MM
J Immunol; 1972 Dec; 109(6):1174-81. PubMed ID: 4628703
[No Abstract] [Full Text] [Related]
2. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
Brade V; Nicholson A; Lee GD; Mayer MM
J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
[No Abstract] [Full Text] [Related]
3. Purification and some properties of a heat labile serum factor (UP); identity with glycine-rich beta-glycoprotein and properdin factor B.
Lynen R; Brade V; Wolf A; Vogt W
Hoppe Seylers Z Physiol Chem; 1973 Jan; 354(1):37-47. PubMed ID: 4214745
[No Abstract] [Full Text] [Related]
4. The relationship of glycine-rich -glycoprotein to factor B in the properdin system and to the cobra factor-binding protein of huan serum.
Alper CA; Goodkofsky I; Lepow IH
J Exp Med; 1973 Feb; 137(2):424-37. PubMed ID: 4734403
[TBL] [Abstract][Full Text] [Related]
5. Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose.
Vogt W; Schmidt G; Dieminger L; Lynen R
Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(5):440-55. PubMed ID: 126576
[TBL] [Abstract][Full Text] [Related]
6. Separation of different serological activities associated with immunoglobulins from sera of rabbits immunized with rat erythrocytes.
Kastelan M; Vitale L; Vitale B
Eur J Immunol; 1971 Nov; 1(5):363-6. PubMed ID: 5003356
[No Abstract] [Full Text] [Related]
7. The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.
Stitzel AE; Spitzer RE
J Immunol; 1974 Jan; 112(1):56-62. PubMed ID: 4130153
[No Abstract] [Full Text] [Related]
8. Activation of the alternative (properdin) pathway by divalent cations.
Lew FT; Yukiyama Y; Waks HS; Osler AG
J Immunol; 1975 Sep; 115(3):884-8. PubMed ID: 807649
[TBL] [Abstract][Full Text] [Related]
9. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
May JE; Frank MM
J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
[No Abstract] [Full Text] [Related]
10. Heat labile opsonin system to pneumococcus.
Shin HS; Smith MR; Winkelstein J; Nicholson A
Birth Defects Orig Artic Ser; 1975; 11(1):563-6. PubMed ID: 238689
[TBL] [Abstract][Full Text] [Related]
11. Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.
Bitter-Suermann D; Dierich M; König W; Hadding U
Immunology; 1972 Sep; 23(3):267-81. PubMed ID: 4214761
[TBL] [Abstract][Full Text] [Related]
12. Studies on the third component (C'3) of guinea pig complement. I. Purification and characterization.
Yonematsu K; Inoue K
Biken J; 1968 Sep; 11(3):169-80. PubMed ID: 4976235
[No Abstract] [Full Text] [Related]
13. Detection, separation and characterization of organ specific antigens of human thrombocytes.
Hanna N; Nelken D
Immunology; 1971 Apr; 20(4):533-43. PubMed ID: 4101706
[TBL] [Abstract][Full Text] [Related]
14. Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.
Brade V; Nicholson A; Bitter-Suermann D; Hadding U
J Immunol; 1974 Dec; 113(6):1735-43. PubMed ID: 4279261
[No Abstract] [Full Text] [Related]
15. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.
Volanakis JE; Kaplan MH
J Immunol; 1974 Jul; 113(1):9-17. PubMed ID: 4208926
[No Abstract] [Full Text] [Related]
16. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
[No Abstract] [Full Text] [Related]
17. C3b inactivator of man. 3. Further purification and production of antibody to C3b INA.
Ruddy S; Hunsicker LG; Austen KF
J Immunol; 1972 Mar; 108(3):657-64. PubMed ID: 4622188
[No Abstract] [Full Text] [Related]
18. Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.
Ruley EJ; Forristal J; Davis NC; Andres C; West CD
J Clin Invest; 1973 Apr; 52(4):896-904. PubMed ID: 4693654
[TBL] [Abstract][Full Text] [Related]
19. C3 inactivating factor in the serum of a patient with chronic hypocomplementaemic proliferative glomerulo-nephritis.
Thompson RA
Immunology; 1972 Jan; 22(1):147-58. PubMed ID: 4622449
[TBL] [Abstract][Full Text] [Related]
20. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
Ballow M; Cochrane CG
J Immunol; 1969 Nov; 103(5):944-52. PubMed ID: 4981797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
